Guided Therapeutics (GTHP) Revenue (2010 - 2025)
Guided Therapeutics recorded quarterly Revenue of $590000.0 in Q4 2025, up 883.33% quarter-over-quarter from $60000.0 in Q3 2025, and up 58900.0% year-over-year from N/an in Q4 2024.
Guided Therapeutics' Revenue history runs 16 years deep, the most recent figure standing at $590000.0 for Q4 2025.
- In Q4 2025, Revenue rose 58900.0% year-over-year to $590000.0; the TTM figure through Dec 2025 stood at $767000.0 (up 10857.14% YoY), while the FY2025 annual figure was $767000.0, up 10857.14% from the prior year.
- Revenue came in at $590000.0 for Q4 2025 at Guided Therapeutics, up from $60000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $590000.0 in Q4 2025 to a low of $1000.0 in Q4 2024.
- A 5-year average of $69000.0 and a median of $20500.0 in 2021 frame the typical range for Revenue.
- Across the five-year window, Revenue tumbled 96.88% in 2024 and jumped 58900.0% in 2025, its largest moves.
- Guided Therapeutics' Revenue stood at $60000.0 in 2021, then slumped by 95.0% to $3000.0 in 2022, then surged by 966.67% to $32000.0 in 2023, then sank by 96.88% to $1000.0 in 2024, then surged by 58900.0% to $590000.0 in 2025.
- According to Business Quant data, Revenue over the past three periods registered $590000.0, $60000.0, and $117000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 11.16 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.02 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 9.02 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 5.20 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.65 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.57 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1.19 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 5.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 1.59 Bn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 590,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 590,000.00 |
| Sep 30, 2025 | 60,000.00 |
| Jun 30, 2025 | 117,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 32,000.00 |
| Jun 30, 2023 | 44,000.00 |
| Mar 31, 2023 | 22,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Dec 31, 2021 | 60,000.00 |
| Sep 30, 2021 | 19,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Dec 31, 2020 | 25,000.00 |
| Sep 30, 2020 | 77,000.00 |
| Dec 31, 2019 | 16,000.00 |
| Sep 30, 2019 | 1,000.00 |
| Jun 30, 2019 | 1,000.00 |
| Mar 31, 2019 | 18,000.00 |
| Dec 31, 2018 | 42,000.00 |
| Sep 30, 2018 | 2,000.00 |
| Jun 30, 2018 | 8,000.00 |
| Mar 31, 2018 | 4,000.00 |
| Dec 31, 2017 | 107,000.00 |
| Sep 30, 2017 | 33,000.00 |
| Jun 30, 2017 | 87,000.00 |
| Mar 31, 2017 | 21,000.00 |
| Dec 31, 2016 | -486,000.00 |
| Sep 30, 2016 | 95,000.00 |
| Dec 31, 2015 | 9,000.00 |
| Sep 30, 2015 | 8,000.00 |
| Jun 30, 2015 | 10,000.00 |
| Mar 31, 2015 | 15,000.00 |
| Dec 31, 2014 | 13,000.00 |
| Sep 30, 2014 | 22,000.00 |
| Jun 30, 2014 | 11,000.00 |
| Mar 31, 2014 | 19,000.00 |
| Dec 31, 2013 | 346,000.00 |
| Sep 30, 2013 | 86,000.00 |
| Jun 30, 2013 | 222,000.00 |
| Mar 31, 2013 | 167,000.00 |
| Dec 31, 2012 | 1.01 Mn |
| Sep 30, 2012 | 693,000.00 |
| Jun 30, 2012 | 915,000.00 |
| Mar 31, 2012 | 718,000.00 |
| Dec 31, 2011 | 896,000.00 |
| Sep 30, 2011 | 1.02 Mn |
| Jun 30, 2011 | 913,000.00 |
| Mar 31, 2011 | 767,000.00 |
| Jun 30, 2010 | 805,000.00 |